FDA approves Xolair to avert severe food allergy reactions
Dr. Jay Lieberman, an allergist-immunologist at University of Tennessee Health Science Center, calls the new treatment option exciting for patients, families and allergists.
UTHSC In the Media
Why virtual learning snow days are bad for everyone’s mental health
“The added burden of a child being home and having to monitor their school is added work that moms don’t have the time for or the capacity,” says Jessi Gold, MD, a psychiatrist who specializes in student mental health at the University of Tennessee Health Science Center.
UT-ORII announces two new UT-ORNL research initiatives
The University of Tennessee-Oak Ridge Innovation Institute, or UT-ORII, has selected circular bioeconomy systems and radiopharmaceutical therapies as its two newest Convergent Research Initiatives (CRIs), areas of joint research for UT and Oak Ridge National Laboratory. Over the next five years, UT and Oak Ridge National Laboratory, or ORNL, will invest $40 million-$20 million per… Read More
ZODIAC clinical trial led by UT Health Science Center professor likely to make major impact on stroke care
Research findings in a clinical trial led by a professor at the University of Tennessee Health Science Center’s College of Nursing are likely to dramatically change care and improve outcomes for patients suffering from acute stroke.
STEM study finds improved outcomes with MMA embolization over standard care in cSDH
At the 2024 International Stroke Conference (ISC; 7–9 February, Phoenix, USA), Adam Arthur (University of Tennessee Health Science Center, Memphis, USA)—co-principal investigator for STEM alongside David Fiorella (Stony Brook Cerebrovascular Center, Stony Brook, USA)—relayed that MMA embolisation with the Squid liquid embolic system (Balt) was deemed superior to standard management on the basis of the… Read More
From mice to men: breaking the transmission cycle of Lyme disease
These events 20 years ago prompted Maria Gomes-Solecki, a Lyme disease vaccine researcher at the University of Tennessee Health Science Center, who was part of the team that developed that vaccine, to try something different.
Tenn. dental school begins construction on training clinic
The University of Tennessee Health Science Center College of Dentistry has started construction on a new dental training clinic.
Renowned Neurosurgeon Dr. Kevin Foley Appointed to Curiteva’s Board of Directors
Curiteva, a privately held manufacturing and technology company announces the appointment of Kevin Foley, MD, to the board of directors. Dr. Foley is a distinguished neurosurgeon, chairman of the Semmes Murphey Neurologic and Spine Institute and a professor of neurosurgery, orthopedic surgery, and biomedical engineering at the University of Tennessee Health Science Center.